The upcoming therapies, Epidiolex by GW Pharmaceuticals and JBPOS0101 by BioPharm Solutions, are anticipated to generate a decent West Syndrome market revenue in the forecast period of 2021-2030. LAS ...
Dublin, July 09, 2020 (GLOBE NEWSWIRE) -- The "West Syndrome - Market Insights, Epidemiology and Forecast to 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. This report ...
West syndrome, the most prevalent type of syndromic epileptic encephalopathy affecting infants, is a devastating and often fatal condition. It is characterized by a triad of symptoms – seizures/spasms ...
Infantile spasms represent a severe epileptic encephalopathy predominantly affecting early childhood, with West syndrome constituting a well‐defined clinical subset marked by a triad of spasms, ...
Children with infantile spasms, a rare form of epileptic seizures, should be treated with one of three recommended therapies and the use of non-standard therapies should be strongly discouraged, ...
Researchers have provided the first demonstration of a progressive increase in epileptic spasms along with learning and memory deficits in an animal model of this disorder. West syndrome, the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback